SYRE
#1026
Spyre Therapeutics, Inc. - Common Stock
93.7 3 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.10%
Monthly Change
+14.91%
6 month change
+181.81%
Year Change
+292.01%
Previous Close
97.7 4
Open
93.7 3
Low
93.7 3
High
93.7 3
Volume
140
Financials
- Market Capitalization 8.14 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.55
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.71% | 7.62 B USD |
Frequently asked questions about Spyre Therapeutics, Inc. - Common Stock
What is the Spyre Therapeutics, Inc. - Common Stock stock price today?
The current price of Spyre Therapeutics, Inc. - Common Stock (SYRE) is 93.73. Over the past 24 hours, the stock has changed by -4.10%. Follow the SYRE chart for real-time price dynamics.
What is the stock ticker of Spyre Therapeutics, Inc. - Common Stock?
Spyre Therapeutics, Inc. - Common Stock trades under the ticker SYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spyre Therapeutics, Inc. - Common Stock stock going up?
SYRE has changed by +5.46% over the last week, +14.91% over the last month, and +292.01% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Spyre Therapeutics, Inc. - Common Stock net income for the last quarter?
Spyre Therapeutics, Inc. - Common Stock reported net income of -69 M for the last quarter. The previous quarter showed -62.53 M, which means net income changed by -10.36%.
How many employees does Spyre Therapeutics, Inc. - Common Stock have?
As of the latest available data, Spyre Therapeutics, Inc. - Common Stock has 112 employees. Workforce size can provide additional context about the company's scale and operations.
What is Spyre Therapeutics, Inc. - Common Stock EBITDA?
Spyre Therapeutics, Inc. - Common Stock EBITDA is -77.97 M, and its EBITDA margin is 257.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Spyre Therapeutics, Inc. - Common Stock stock?
You can buy Spyre Therapeutics, Inc. - Common Stock (SYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spyre Therapeutics, Inc. - Common Stock stock?
Investing in Spyre Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SYRE chart and related analysis on metatrader.com as part of your research.